Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C

被引：0
|
作者：
Firpi, RJ [1 ]
Nelson, DR [1 ]
Soldevila, C [1 ]
Abdelmalek, MF [1 ]
Reed, A [1 ]
Hemming, A [1 ]
Howard, R [1 ]
Van der Werk, W [1 ]
Lauwers, G [1 ]
Davis, GL [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
495
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [41] Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
    Lin, Ta-Ya
    Yeh, Ming-Lun
    Huang, Ching-I
    Chen, Yao-Li
    Dai, Chia-Yen
    Huang, Jee-Fu
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Chung-Feng
    Yu, Ming-Lung
    Chuang, Wan-Long
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2017, 33 (06): : 284 - 289
  • [42] Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatment
    Smallwood, GA
    Devine, R
    Lehneman, J
    Connor, K
    Stieber, AC
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 500 - 500
  • [43] Impact of pegylated interferon α-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C:: an open-label series
    Mukherjee, Sandeep
    Lyden, Elizabeth
    LIVER INTERNATIONAL, 2006, 26 (05) : 529 - 535
  • [44] Peginterferon Alfa 2a/ribavirin versus Peginterferon Alfa 2b/ribavirin combination therapy in chronic Hepatitis C genotype 3
    Khan, Arif Q.
    Awan, Ali
    Shahbuddin, Sultan
    Igbal, Qamar
    GASTROENTEROLOGY, 2007, 132 (04) : A200 - A200
  • [45] Treatment of Recurrent Hepatitis C (Genotype 1) with Pegylated Interferon Alfa-2b and Ribavirin Combination and Maintenance Therapy
    Testino, Gianni
    Sumberaz, Alessandro
    Ansaldi, Filippo
    Borro, Paolo
    Leone, Silvia
    Ancarani, A. Ornella
    Gentile, Raffaella
    Icardi, Giancarlo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 536 - 538
  • [46] Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin
    Ahmad, J
    Dodson, SF
    Demetris, AJ
    Fung, JJ
    Shakil, AO
    LIVER TRANSPLANTATION, 2001, 7 (10) : 863 - 869
  • [47] Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α2b and ribavirin:: An open-label series
    Rodriguez-Luna, H
    Khatib, A
    Sharma, P
    De Petris, G
    Williams, JW
    Ortiz, J
    Hansen, K
    Mulligan, D
    Moss, A
    Douglas, DD
    Balan, V
    Rakela, J
    Vargas, HE
    TRANSPLANTATION, 2004, 77 (02) : 190 - 194
  • [48] Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation
    Castedal, M
    Siewert-Delle, A
    Olausson, M
    Friman, S
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 820 - 821
  • [49] Pegylated interferon alfa 2b and ribavirin for hepatitis C patients who were nonresponders to previous
    Lawitz, EJ
    Bala, NS
    Becker, S
    Brown, G
    Davis, M
    Dhar, R
    Ganeshappa, KP
    Gordon, S
    Holtzmuller, K
    Jeffries, M
    Li, JJ
    Monsour, H
    Nader, P
    Rosenfield, T
    Tolman, K
    Kadakia, S
    GASTROENTEROLOGY, 2003, 124 (04) : A783 - A784
  • [50] Treatment with combination of PEG IFN α-2B and ribavirin suppresses viral replication in liver transplantation recipients with recurrent HCV hepatitis
    Khatib, MA
    Arenas, JI
    Carey, E
    Moss, A
    Mulligan, D
    Ortiz, L
    Hansen, K
    Harrison, ME
    Douglas, D
    Balan, V
    Rakela, J
    Vargas, HE
    HEPATOLOGY, 2002, 36 (04) : 182A - 182A
12345